Pharma · Private company
Ipsen
Track this companyFree. Adds Ipsen to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline19
- Botulinum toxin type APhase 3 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Botulinum toxin type APhase 3 · Chronic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- CorabotasePhase 3 · Moderate to Severe Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- ElafibranorPhase 3 · Primary Biliary Cholangitis (PBC)ClinicalTrials.gov · fetched Nov 12, 2026
- ElafibranorPhase 3 · Primary Sclerosing CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- Elafibranor 80mgPhase 3 · Primary Biliary CirrhosisClinicalTrials.gov · fetched Nov 12, 2026
- CorabotasePhase 2 · Cervical DystoniaClinicalTrials.gov · fetched Nov 12, 2026
- CorabotasePhase 2 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- CorabotasePhase 2 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Corabotase dose APhase 2 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Corabotase dose BPhase 2 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- DysportPhase 2 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- Elafibranor 120 mgPhase 2 · Primary Sclerosing CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- Elafibranor 80 mgPhase 2 · Primary Sclerosing CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- IPN01194Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IPN01195Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- IPN01203Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- IPN60300Phase 2 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ElafibranorPregnancy RelatedClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During PregnancyRECRUITING · started Jul 29, 2026ClinicalTrials.gov NCT07556913 · fetched Nov 12, 2026
- A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing CholangitisPHASE3 · RECRUITING · started May 14, 2026ClinicalTrials.gov NCT07387549 · fetched Nov 12, 2026
- A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 27, 2026ClinicalTrials.gov NCT07427797 · fetched Nov 12, 2026
- A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 18, 2026ClinicalTrials.gov NCT07435428 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor TherapiesPHASE1_PHASE2 · RECRUITING · started Feb 6, 2026ClinicalTrials.gov NCT07213830 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursPHASE1_PHASE2 · RECRUITING · started Dec 5, 2025ClinicalTrials.gov NCT07213817 · fetched Nov 12, 2026
- A Study of IPN10200 for the Treatment of Cervical Dystonia in AdultsPHASE2 · RECRUITING · started Jun 30, 2025ClinicalTrials.gov NCT06937931 · fetched Nov 12, 2026
- A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentRECRUITING · started Apr 22, 2025ClinicalTrials.gov NCT06850038 · fetched Nov 12, 2026
- A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid TumoursPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 14, 2025ClinicalTrials.gov NCT06833008 · fetched Nov 12, 2026
- A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)RECRUITING · started Dec 5, 2024ClinicalTrials.gov NCT06089616 · fetched Nov 12, 2026
- A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing TreatmentACTIVE_NOT_RECRUITING · started Oct 14, 2024ClinicalTrials.gov NCT06447168 · fetched Nov 12, 2026
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 10, 2024ClinicalTrials.gov NCT06625060 · fetched Nov 12, 2026
- A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid TumoursPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 3, 2024ClinicalTrials.gov NCT06305247 · fetched Nov 12, 2026
- A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its DevelopmentACTIVE_NOT_RECRUITING · started Nov 1, 2023ClinicalTrials.gov NCT06055725 · fetched Nov 12, 2026
- Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal CancerPHASE2 · RECRUITING · started Oct 13, 2023ClinicalTrials.gov NCT05854498 · fetched Nov 12, 2026
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 12, 2023ClinicalTrials.gov NCT06047444 · fetched Nov 12, 2026
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 29, 2023ClinicalTrials.gov NCT06047457 · fetched Nov 12, 2026
- Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or LactationRECRUITING · started Sep 28, 2023ClinicalTrials.gov NCT06258902 · fetched Nov 12, 2026
- A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisPHASE3 · RECRUITING · started Aug 31, 2023ClinicalTrials.gov NCT06016842 · fetched Nov 12, 2026
- A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)PHASE2 · RECRUITING · started May 12, 2023ClinicalTrials.gov NCT05851924 · fetched Nov 12, 2026
- A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 29, 2022ClinicalTrials.gov NCT05627362 · fetched Nov 12, 2026
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.PHASE1_PHASE2 · RECRUITING · started Apr 29, 2021ClinicalTrials.gov NCT04752774 · fetched Nov 12, 2026
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)PHASE3 · ACTIVE_NOT_RECRUITING · started Sep 24, 2020ClinicalTrials.gov NCT04526665 · fetched Nov 12, 2026
- NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 29, 2019ClinicalTrials.gov NCT04005339 · fetched Nov 12, 2026
- A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 5, 2018ClinicalTrials.gov NCT03690388 · fetched Nov 12, 2026